Canada markets open in 6 hours 8 minutes

Marinus Pharmaceuticals, Inc. (MRNS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.4100-0.0300 (-2.08%)
At close: 04:00PM EDT
1.4100 0.00 (0.00%)
After hours: 07:45PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 77.45M
Enterprise Value 912.77k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.45
Price/Book (mrq)4.62
Enterprise Value/Revenue 0.03
Enterprise Value/EBITDA -0.01

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 3-82.59%
S&P500 52-Week Change 321.23%
52 Week High 311.2600
52 Week Low 31.1100
50-Day Moving Average 38.5650
200-Day Moving Average 38.3348

Share Statistics

Avg Vol (3 month) 31.6M
Avg Vol (10 day) 37.69M
Shares Outstanding 554.93M
Implied Shares Outstanding 659.51M
Float 842.76M
% Held by Insiders 10.97%
% Held by Institutions 198.62%
Shares Short (Mar 28, 2024) 43.47M
Short Ratio (Mar 28, 2024) 46.33
Short % of Float (Mar 28, 2024) 46.41%
Short % of Shares Outstanding (Mar 28, 2024) 46.36%
Shares Short (prior month Feb 29, 2024) 43.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sept 23, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Sept 23, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-492.86%

Management Effectiveness

Return on Assets (ttm)-38.19%
Return on Equity (ttm)-213.02%

Income Statement

Revenue (ttm)30.99M
Revenue Per Share (ttm)0.58
Quarterly Revenue Growth (yoy)0.40%
Gross Profit (ttm)N/A
EBITDA -126.13M
Net Income Avi to Common (ttm)-141.4M
Diluted EPS (ttm)-2.6300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)150.29M
Total Cash Per Share (mrq)2.75
Total Debt (mrq)110.36M
Total Debt/Equity (mrq)658.26%
Current Ratio (mrq)4.07
Book Value Per Share (mrq)0.31

Cash Flow Statement

Operating Cash Flow (ttm)-118M
Levered Free Cash Flow (ttm)-70.09M